Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -52.61% is 108% below its 5-year average of -25.28%, around the middle of its 5-year range (-95.87%–-11.97%).
As of the fiscal period ended Tuesday, June 30, 2026. 80.30% below its 12-month average of -29.18%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -52.61%.
RETURN ON INVESTED CAPITAL (ROIC)
-52.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-29.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-38.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-25.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-66.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-54.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-80.30%
CURRENT VS 3Y AVG
-34.98%
CURRENT VS 5Y AVG
-108.11%
CURRENT VS 10Y AVG
+21.29%
CURRENT VS 15Y AVG
+3.05%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.80%
median of 696 covered companies
CURRENT VS SECTOR MEDIAN
-55.66%
vs the sector median at left
Grace Therapeutics, Inc.
Market Cap
$34.58M
Return on Invested Capital (ROIC)
-52.61%
TTM Avg
-29.18%
3Y Avg
-38.98%
5Y Avg
-25.28%
Market Cap
$34.56M
Return on Invested Capital (ROIC)
-10.09%
TTM Avg
-4.30%
3Y Avg
-1.90%
5Y Avg
0.50%
Market Cap
$33.93M
Return on Invested Capital (ROIC)
-207.97%
TTM Avg
-157.56%
3Y Avg
-117.52%
5Y Avg
-96.17%
Market Cap
$35.42M
Return on Invested Capital (ROIC)
-79.27%
TTM Avg
-43.87%
3Y Avg
-333.47%
5Y Avg
-212.56%
Market Cap
$35.62M
Return on Invested Capital (ROIC)
-164.58%
TTM Avg
-155.30%
3Y Avg
-94.59%
5Y Avg
-73.98%
Market Cap
$35.76M
Return on Invested Capital (ROIC)
-89.44%
TTM Avg
-27.62%
3Y Avg
-11.28%
5Y Avg
-9.71%
Market Cap
$36.23M
Return on Invested Capital (ROIC)
-171.36%
TTM Avg
-234.34%
3Y Avg
-204.54%
5Y Avg
-189.00%
Market Cap
$32.76M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-107.47%
3Y Avg
-107.47%
5Y Avg
-107.47%
Market Cap
$36.63M
Return on Invested Capital (ROIC)
-22.79%
TTM Avg
-490.24%
3Y Avg
-256.92%
5Y Avg
-224.31%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $34.58M | -52.61% | -29.18% | -38.98% | -25.28% |
| Accuray Incorporated (ARAY)vs › | $34.56M | -10.09% | -4.30% | -1.90% | 0.50% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.93M | -207.97% | -157.56% | -117.52% | -96.17% |
| Elutia Inc (ELUT)vs › | $35.42M | -79.27% | -43.87% | -333.47% | -212.56% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.62M | -164.58% | -155.30% | -94.59% | -73.98% |
| DocGo Inc. (DCGO)vs › | $35.76M | -89.44% | -27.62% | -11.28% | -9.71% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.23M | -171.36% | -234.34% | -204.54% | -189.00% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | N/A | -107.47% | -107.47% | -107.47% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.63M | -22.79% | -490.24% | -256.92% | -224.31% |
| HeartBeam, Inc. (BEAT)vs › | $32.32M | -249.58% | -1007.23% | -664.86% | -535.30% |
ROIC
-52.6%
ROE
-44.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -52.61% |
| 2026-03-31 | -20.13% |
| 2025-12-31 | -21.59% |
| 2025-09-30 | -25.22% |
| 2025-06-30 | -26.35% |
| 2025-03-31 | -30.66% |
| 2024-12-31 | -36.07% |
| 2024-09-30 | -32.04% |
| 2024-06-30 | -26.94% |
| 2024-03-31 | -24.01% |
| 2023-12-31 | -86.33% |
| 2023-09-30 | -85.78% |
| 2023-06-30 | -95.87% |
| 2023-03-31 | -90.25% |
| 2022-12-31 | -19.76% |
| 2022-09-30 | -19.13% |
| 2022-06-30 | -17.99% |
| 2022-03-31 | -15.62% |
| 2021-12-31 | -15.26% |
| 2021-09-30 | -11.97% |
| 2021-06-30 | -34.44% |
| 2021-03-31 | -35.53% |
| 2020-12-31 | -79.84% |
| 2020-09-30 | -245.02% |
| 2020-06-30 | -132.26% |
| 2020-03-31 | -90.06% |
| 2019-12-31 | -150.74% |
| 2019-09-30 | -178.13% |
| 2019-06-30 | -197.49% |
| 2019-03-31 | -140.93% |
| 2018-12-31 | -89.33% |
| 2018-09-30 | -479.72% |
| 2018-06-30 | -166.41% |
| 2018-03-31 | -127.00% |
| 2016-11-30 | -51.92% |
| 2016-08-31 | -44.97% |
| 2016-05-31 | -39.41% |
| 2016-02-29 | -37.21% |
| 2015-11-30 | -35.16% |
| 2015-08-31 | -35.88% |
| 2015-05-31 | -38.66% |
| 2015-02-28 | -39.94% |
| 2014-11-30 | -32.51% |
| 2014-08-31 | -29.93% |
| 2014-05-31 | -27.76% |
| 2014-02-28 | -25.53% |
| 2013-11-30 | -51.98% |
| 2013-08-31 | -41.31% |
| 2013-05-31 | -90.14% |
| 2013-02-28 | -72.60% |
| 2012-11-30 | -60.06% |
| 2012-08-31 | -57.42% |
| 2012-05-31 | -57.02% |
| 2012-02-29 | -45.93% |
| 2011-11-30 | -46.90% |
| 2011-08-31 | -59.74% |
| 2011-05-31 | -36.31% |
| 2011-02-28 | -48.17% |
| 2010-02-28 | -36.99% |
